Sg Americas Securities, LLC Maxcyte, Inc. Transaction History
Sg Americas Securities, LLC
- $24.4 Billion
- Q4 2024
A detailed history of Sg Americas Securities, LLC transactions in Maxcyte, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 47,805 shares of MXCT stock, worth $243,805. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47,805
Previous 37,969
25.91%
Holding current value
$243,805
Previous $148,000
34.46%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding MXCT
# of Institutions
125Shares Held
65.6MCall Options Held
1KPut Options Held
2K-
Cadian Capital Management, LP New York, NY8.19MShares$41.8 Million1.63% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$41.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.78MShares$29.5 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$25.7 Million7.62% of portfolio
-
Morgan Stanley New York, NY4.82MShares$24.6 Million0.0% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $519M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...